Host defence mechanisms in Burkitt's lymphoma and Kaposi's sarcoma: the clinical evidence.
D002051:Burkitt Lymphoma / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D006968:Hypersensitivity, Delayed; D008198:Lymph Nodes; D008727:Methotrexate / Q000627:therapeutic use; D009365:Neoplasm Regression, Spontaneous; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D011379:Prognosis; D012514:Sarcoma, Kaposi / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D014750:Vincristine / Q000627:therapeutic use
D009588:Nitrogen Mustard Compounds; D014750:Vincristine; D003520:Cyclophosphamide; D008727:Methotrexate